Inhibition of avian myeloblastosis virus (AMV)reverse transcriptase by natural and synthetic quinones including antibiotics could be accounted for by an oxidation-reduction reaction. The quinones were shownto function as electron acceptors as revealed by the catalytic oxidation of NADHby Clostridium kluyveri diaphorase which was in excellent agreement with enzyme inhibition activity.
Inhibition of avian myeloblastosis virus (AMV)reverse transcriptase by natural and synthetic quinones including antibiotics could be accounted for by an oxidation-reduction reaction. The quinones were shownto function as electron acceptors as revealed by the catalytic oxidation of NADHby Clostridium kluyveri diaphorase which was in excellent agreement with enzyme inhibition activity.
The kinetics of inhibition of AMVreverse transcriptase by three synthetic quinones with different core structures, i.e., 6-methoxy -5,8-dihydroquinoline-5,8-dione, 5,8-dihydroisoquinoline-5,8-dione and 1 ,4-naphthoquinone, were studied. These quinones inhibited reverse transcriptase in the same manner as streptonigrin (STN) and were shown to act at a single class of reaction site(s) on the enzyme molecule. In contrast, the quinones with bulky substituents, i.e. , 7-(2-nitrophenethylamino) -5,8-dihydroisoquinoline-5,8-dione and 7-methoxy-6-methyl-3-piperidino-5,8-dihydroisoquinoline-5,8-dione, were inactive as inhibitors of reverse transcriptase, whereas they retained competent catalytic activities in the oxidation of NADHby C. kluyveri diaphorase. Based on these observations, the existence of a specific site of interaction on the enzymemolecule, referred to as a quinone pocket, was proposed. The quinone pocket might play a crucial role in the early sequence of events leading to the inhibition of reverse transcriptase by quinones including STN and sakyomicin A (SKM). Access of SKMto a quinone pocket might be restricted due to its bulky structure in the vicinity of the quinone group. This is inferred from unsuccessful inhibition of reverse transcriptase by the quinones with bulky substituents, resulting in much poorer inhibition of reverse transcriptase in spite of more potent electron acceptor activity in the oxidationreduction system as comparedwith those of STN.
Streptonigrin (STN) was first reported as an antitumor antibiotic by Rao and Cullen0 Later, potent inhibition of avian myeloblastosis virus (AMV)reverse transcriptase by STNwas observed by Chirigos et al.2\ STNshowed specificity for AMVreverse transcriptase in comparison with calf thymus DNAdependent DNApolymerase (DDDP) alpha and Escherichia coli DDDPI3). By using various quinones, the importance of the role of the quinone group in the biological activities of STN and good correlation between electron acceptor activities in the oxidation of NADH by Clostridium kluyveri diaphorase and inhibitory activities against AMV reverse transcriptase were reported previously4~6). Depending on these observations, the specificity shown by STNare considered to derive from the OCT. 1988 high sensitivity of AMVreverse transcriptase to the oxidation-reduction reaction mediated by quinones including STN.
Inhibition of AMVreverse transcriptase by STNwas characterized to be noncompetitive with respect to substrate and might depend on direct interaction between STNand the enzyme molecule or be mediated by molecular oxygen7*8). The combined addition of NADH and diaphorase to the enzyme assay system, however, could not afford any effect on the inhibition of AMVreverse transcriptase by the quinone antibiotics, STN and sakyomicin A (SKM)9) ; the latter is another type of quinone antibiotic showing inhibition of AMV reverse transcriptase. SKMwas more potent as an electron acceptor in NADH/C. kluyveri diaphorase system but less active as an inhibitor of reverse transcriptase when compared with STN9). In this paper, the kinetics of inhibition of AMVreverse transcriptase and the biological properties of the synthetic quinones were studied in an attempt to find clues to these questions.
Materials and Methods

Materials
Isolation of STNwas conducted following the previously reported method10). Mimosamycin (7), an antibiotic produced by Streptomyces lavendulae No. 314, was obtained as reported previous-
The details of preparation of 6-methoxy-
5,8-diacetoxy-7-methoxy-6-methyl-3-piperidinoisoquinoline (10) were reported previously12"170. 2-ethyl-l,4-naphthoquinone (14) and 2-amino-l,4-naphthoquinone (15) will be published elsewhere. 1,4-Naphthoquinone (ll) was purchased from Tokyo Kasei Kogyo Co., Ltd. 2-Amino-3-chloro-l,4-naphthoquinone (17) was a product of Aldrich Chemicals., Inc. Vitamin Ki (18) was obtained from Nakarai Chemicals Ltd. Reverse transcriptase from AMVwas purchased from Seikagaku Kogyo Co., Ltd. Diaphorase of C. kluyveri origin was a product of Oriental Yeast Co., Ltd. Poly(rA) and oligo(dT)12_18 were obtained from Sigma Chemical Co., Ltd. and Pharmacia (Japan) Kabushiki Kaisha, respectively. All other chemicals were commercial products of analytical grade.
Assay Methods for Biological Activities The details of assay method for AMVreverse transcriptase were described previously3). Briefly, standard assay solution containing 50 him Tris-HCl (pH 8.0), 2.5 mMMgCl2, 2.5 mMdithiothreitol, 30 mM NaCl, 100 jum thymidine-5' -triphosphate (TTP), 6^Ci/ml [3H]TTP, 5 //g/ml poly(rA), 0.25^g/ml oligo(dT)12_18 and 3.0 u/ml reverse transcriptase in a final volume of 100 iA was incubated at 37°C for 30 minutes, unless otherwise specified. The rate of incorporation of [3H]TTPinto high molecular fractions was proportional to the reaction time up to 30 minutes.
The method for culture of murine lymphoblastoma L5178Ycells was described in a previous paper18).
Determination of Hydrogen Peroxide Hydrogen peroxide was determined by the method of Trinder19) with some modifications as described in a previous paper9). The reaction mixture (2.5 ml) consisting of 10 mMTris-HCl (pH 8.0), 0.54 mM4-aminoantipyrine, 0.006% phenol and 6 u/ml peroxidase was incubated at 37°C for 20 minutes. Fig. 1 . Structures of streptonigrin, sakyomicin A and the quinones.
Results
Enzymeactivity was measuredin the presence of different concentrations of individual components of reaction mixture, while the other componentswere kept at the sameconcentrations as those in the standard reaction mixture. The results summarized in Table 1 demonstrate that inhibition of reverse transcriptase was most efficiently reversed by increasing the concentration of enzyme. In contrast, increase in the concentration of poly(rA)-oligo(dT)12_18 was accompanied by marginal enhancement in inhibition of reverse transcriptase by 1, 2 or ll, whereas the concentration of TTP had no effect on inhibition of reverse transcriptase.
Incubation of reverse transcriptase with 1, 2 or ll in advance of the constitution of a complete reaction mixture potentiated inhibition of reverse transcriptase (Fig. 2) . A reaction mixture in a final volume of 100 [A was incubated at 37°C for 30 minutes. After the reaction was terminated by cooling in an ice bath, 50-^1 aliquot was soaked into a 2.4 cm-round piece of DEAEcellulose paper which was washed three times with 5 % Na2HPO4 -12H2Oand once each with distilled water and ethanol. The radioactivities of [3H]TTP incorporated in the absence (a) and presence (b) of the individual quinones were used to calculate inhibition (%) which was defined in the following equation: Inhibition (%)={\ -b/a) x 100. The quinones were used at the concentrations which were expected to give approximately 50%inhibition under the standard reaction conditions (refer to Table 2) .
NT: Nottested. In contrast, the kinetic parameters obtained as a function of the concentration of template-primer indicate that inhibition of reverse transcriptase was uncompetitive (data not shown).
The dose-response data were constructed in modified Scatchard plots (Fig. 4) . From the results, the existence of a single class of reaction site(s) on the enzymemolecule was evident for all the quinone compounds tested including STN.
The effects of quinones on [3H]TTPincorporation in an ongoing reaction are shown in Fig. 5 .
In all cases, the rate of [3H]TTP incorporation was inhibited following a short time lag. The results indicate that all the quinones inhibit DNAsynthesis at the elongation step as in the case of STN7).
Comparative biological properties of various quinone antibiotics and synthetic compounds are shown in Table 2 . The data for STN, SKM, 1, ll, 12, 13 and 16 are cited from previous reports3*4>6>2°,21). The existence of the hydroxyl group at ortko-position to the carbonyl group on the quinonering, as in the case of 5 or 12, nullified all biological activities and the requirement for a role of the quinone group in effective inhibition of reverse transcriptase and electron acceptor function coupled with the oxidation of NT: Not tested. The quinones were added to a reaction mixture at the times indicated by the arrows at the final concentration of 2.5 /ig/ml. NADHby C. kluyveri diaphorase was shown by the results for 7.^ara-Isoquinoline quinones with rather bulky substituent, 4 and 6, were devoid of inhibitory activity against reverse transcriptase, although their activities as electron acceptors were comparable to those of the other compounds. Electron acceptor and cytocidal activities of 3 were higher than those of 2 owing to the contribution of the amino group at C-7 on the 5,8-dihydroisoquinoline-5,8-dion structure. In contrast, the amino group at C-2 on the 1,4-naphthoquinone structure had adverse effect on these activities ofnaphthoquinones as can be deduced from the results for ll, 15, 16 and 17, whereas reverse transcriptase was inhibited by them to the same extents. Regarding the alkyl substituents at C-2 and/or C-3 on the 1,4-naphthoquinone structure, chain elongation was inversely correlated with biological activities as exemplified by the results for 13, 14 and 18.
Discussion
The specificity of STNfor AMVreverse transcriptase elicited our great interest in the elucidation of mechanisms by which STNinterferes with the enzyme reaction. The quinoline quinone moiety of STNwas shown to play an important role in inhibition of AMV reverse transcriptase as seen by examination of comparative biological properties of two quinoline quinone derivatives and STN4).
However, it remained unsolved whether the quinones inhibited AMV reverse transcriptase in a similar manner to STN. The synthetic quinones, 1, 2 and ll, inhibited AMVreverse transcriptase due to direct interaction with the enzymemolecule in a noncompetitive mannerwith respect to substrate as in the case of STN. The uncompetitive inhibition with respect to template-primer suggests that the enzyme becomes more susceptible to quinone-dependent inactivation provided that it forms a complex with template-primer, resulting in an enhanced inactivation of the enzymeat the higher concentrations of template-primer ( Table 1) . The results shown in Fig. 4 suggest the existence of a single class of interaction site(s) on the enzyme molecule for all the quinones and STN. The lack of inhibitory activity against AMVreverse transcriptase in the quinones with rather bulky substituent such as 4 and 6 inspite of their competenceas electron acceptors is similar to the discrepancy observed between those activities of SKM. The previous observation that quinone antibiotic-induced inhibition of AMV reverse transcriptase was not potentiated by the supplementation of NADHand C. kluyveri diaphorase to the reaction mixture*0 excludes the possibility that a series of events resulting in inhibition of reverse transcriptase are mediated by molecular oxygen, supporting the postulation of a quinone pocket, which in turn gave STN specificity for AMVreverse transcriptase.
